Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the US market, where an authorised generic sold under license from AZ has been available since ...

Symbicort was first FDA-approved in 2006 as ... a long-acting beta2-agonist bronchodilator with a fast action, in a single inhaler. A Viatris spokesperson said: "Viatris obviously disagrees ...

Medically reviewed by Brian Bezack, DO Inhalers are medical devices used to deliver a dose of medication into your lungs to ...

Cipla announced that it filed two generic respiratory drug applications with the US FDA in the last quarter, including a generic version of Symbicort and one other undisclosed inhalation product.